Showing results (991-1000 of 1,586) with videos related to

Sort By:
Pageof 159
JAMA Dermatology|November 27, 2014
MEK inhibitor-induced dusky erythema: characteristic drug hypersensitivity manifestation in 3 patientsUrvi Patel, Lynn Cornelius, Milan J Anadkat
JAMA Dermatology|October 16, 2014
Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndromeTarun Mehra, Kristian Ikenberg, Rudolf Maria Moos, et al.
JAMA Dermatology|November 18, 2020
Psoriasis Flares Following Systemic Glucocorticoid Exposure in Patients With a History of PsoriasisAnna R F Gregoire, Britt K DeRuyter, Erik J Stratman
JAMA Dermatology|September 3, 2020
Association Between Drug Use and Subsequent Diagnosis of Lupus ErythematosusJeanette Halskou Haugaard, Kristian Kofoed, Gunnar Gislason, et al.
JAMA Dermatology|November 4, 2020
Sebaceous Carcinoma Incidence and Survival Among Solid Organ Transplant Recipients in the United States, 1987-2017Michael R Sargen, Elizabeth K Cahoon, Charles F Lynch, et al.
JAMA Dermatology|February 13, 2020
Treatment of Childhood-Onset Lupus Erythematosus Panniculitis With RituximabColleen K Correll, Daniel D Miller, Sheilagh M Maguiness
JAMA Dermatology|February 13, 2020
Comparison of Tightly Controlled Dose Reduction of Biologics With Usual Care for Patients With Psoriasis: A Randomized Clinical TrialSelma Atalay, Juul M P A van den Reek, Alfons A den Broeder, et al.
JAMA Dermatology|December 12, 2019
Noncutaneous and Cutaneous Cancer Risk in Patients With Atopic Dermatitis: A Systematic Review and Meta-analysisLily Wang, Rachel Bierbrier, Aaron M Drucker, et al.
Pageof 159